Q2 2021 Holdings
Filed 2021-08-11 | 67 holdings | $55.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $201 | 9,500 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $259 | 10,000 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $292 | 20,000 | 0.0% |
| Bluebird Bio Inc | COM | 09609G100 | $351 | 11,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $474 | 25,500 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $503 | 6,000 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $525 | 19,700 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $634 | 60,000 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $682 | 107,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $763 | 21,800 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $912 | 94,600 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $938 | 53,000 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.1K | 45,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.1K | 67,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $1.3K | 10,700 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $1.3K | 15,700 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $1.4K | 21,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | CM | 03753U106 | $1.5K | 23,400 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $1.5K | 34,047 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $1.5K | 58,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.7K | 19,500 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.9K | 101,534 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $2.1K | 17,000 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $2.2K | 70,000 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $2.3K | 12,800 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $2.4K | 170,821 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $2.5K | 31,500 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $2.6K | 139,331 | 0.0% |
| Hutchmed China LTD(HCM) | SPONSORED ADS | 44842L103 | $2.7K | 68,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.7K | 16,900 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $2.8K | 135,000 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $2.8K | 100,100 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $3.2K | 79,456 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $3.6K | 20,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $3.7K | 100,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $3.8K | 82,633 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $4.0K | 58,100 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $4.7K | 166,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $5.7K | 60,100 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $6.2K | 202,436 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.8K | 283,233 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.8K | 152,000 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.3K | 181,781 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $7.6K | 60,500 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $7.8K | 43,300 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $9.5K | 121,541 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $9.7K | 315,500 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $11.5K | 136,860 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $12.4K | 51,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $13.1K | 64,822 | 0.0% |